February 2024
Bio Usawa Inc. team led by Dr. Menghis Bairu, Co-founder, CEO and President, John Hautman Bio Usawa Chief Legal officer and Bio Usawa Consultant Carolyne Ndolo met with Michael Lusiola, the CEO Bio Vax Institute and Bio Vax Institute Lai Clare Head legal and Board affairs.
The team explored potential avenues for partnership and collaboration in vaccine research and development, capacity building, and human resource development to stay abreast of the latest trends in the vaccine manufacturing sector.
They concurred that forging public-private partnerships is essential to strengthening Africa's foothold as a leader in vaccine research and development.
Bio Usawa, a company focused on producing life-saving, affordable monoclonal therapies for Africa and beyond, congratulates Professor Kwabena Frimpong-M…
July 2025Bio Usawa, a company that is bridging the divide between the world’s leading healthcare markets and the growing demand for access to innovative biologic…
July 2025“The recent revelation that nearly 20% of tested chemotherapy drugs failed basic quality standards is more than just alarming—it is a global public heal…
July 2025